RxDoctor Payments DataLook up a doctor →

Boyd Southwick, DO

Family Medicine · Idaho Falls, IDNPI 1578613337

Payments from drug & device makers

$9,579in general payments, 2019–2025

Across 626 payments — averaging $15.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$682
  • Lilly USA, LLC$672
  • Boehringer Ingelheim$586
  • Novo Nordisk$519
  • Otsuka America Pharmaceutical, Inc.$430
  • plus $4K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)132$2,190
Amgen(2 entities)52$682
Lilly USA, LLC60$672
Boehringer Ingelheim33$586
Novo Nordisk38$519
Otsuka America Pharmaceutical, Inc.29$430
Astellas Pharma US Inc21$388
Antares Pharma, Inc.21$359
GSK24$333
Novartis15$253
Axsome Therapeutics, Inc.14$239
Teva Pharmaceuticals USA, Inc.16$227
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$180
Amarin Pharma, Inc.9$138
AstraZeneca9$136
Pfizer9$126
Vanda Pharmaceuticals Inc.4$117
Sunovion Pharmaceuticals Inc.8$113
Biocryst US Sales Co., LLC5$111
Bayer7$102
Merck6$100
Sanofi Pasteur Inc.4$91
Takeda Pharmaceuticals U.S.A., Inc.7$91
Corium, LLC9$89
Genentech USA, Inc.6$89
Boston Scientific5$85
Johnson & Johnson5$85
Corcept Therapeutics3$63
Shield Therapeutics Inc3$57
Esperion Therapeutics, Inc.4$56
Ionis Pharmaceuticals, Inc.2$49
Ironshore Pharmaceuticals Inc.3$47
Dexcom, Inc.2$45
Acadia Pharmaceuticals Inc3$44
Phathom Pharmaceuticals, Inc.3$43
Neurocrine Biosciences, Inc.2$41
Mylan Specialty L.p.2$40
Arbor Pharmaceuticals, Inc.3$35
Sanofi-aventis U.S. LLC3$34
Neurelis, Inc.2$34
Shire North American Group Inc2$30
Biocryst Pharmaceuticals, Inc.1$30
Eisai Inc.2$29
Pharming Healthcare, Inc.2$28
Impel Pharmaceuticals Inc.2$26
Adlon Therapeutics L.p.2$26
Lundbeck LLC1$24
Alnylam Pharmaceuticals Inc.1$21
Aimmune Therapeutics, Inc.1$19
Ultragenyx Pharmaceutical Inc.1$18
Ipsen Biopharmaceuticals, Inc1$18
Seqirus USA Inc1$18
Gilead1$17
Si-bone, Inc.1$17
CSL Behring1$16
Edwards Lifesciences1$16
Regeneron Healthcare Solutions, Inc.1$15
Xeris Pharmaceuticals, Inc.1$15
Tris Pharma Inc1$14
Therapeuticsmd, Inc.1$14

How this compares

$9,579 in reported general payments places this provider in the 95th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$144,337
Medicare patients
304
Services billed
2,542

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Idaho Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →